Fundz

Araceli Biosciences reported raising $2.53 Million in an initial SEC Form D filing, from an offering of $4.5 Million

PRIVATENov 03, 2026$2.5M of $4.5M raised

Amount Raised

$2.53 Million

$2.53 Million sold, per SEC Form D (first sale Oct 20, 2026)
$4.5 Million per company press release (Nov 12, 2026)

Round Type

Seed

TigardBiotechnologyHealthcare

Investors

Jeff Swickard

Description

Araceli Biosciences, based in Tigard, OR, raised $4.5M in funding to support its commercialization efforts. The company develops cellular imaging platforms for drug discovery. The funds will aid in launching consumable products optimized for its existing market. Founded in 2020, Araceli aims to improve drug development accuracy and efficiency.

Quick answer

Araceli Biosciences raised $2.53 Million in a Seed round, dated October 20, 2026. Investors: Jeff Swickard. Araceli Biosciences is based in Tigard, Oregon, United States.

How much did Araceli Biosciences raise?
Araceli Biosciences raised $2.53 Million in a Seed round on October 20, 2026.
Who invested in Araceli Biosciences?
Jeff Swickard is named as investors in this round.
What does Araceli Biosciences do?
Araceli Biosciences is transforming therapeutic discovery with technologies built for speed, precision, and impact.
Where is Araceli Biosciences based and how big is it?
Araceli Biosciences is based in Tigard, Oregon, United States. Fundz records about 45 employees.
Who are the decision-makers at Araceli Biosciences?
Fundz holds 1 contact at Araceli Biosciences, including the Vice President WW Sales and Support. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Araceli Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • Equinox raised $1B on November 2, 2026.
  • Endovia Health Sciences, Inc. raised $135M (Post-IPO Equity) on October 27, 2026.
  • Recursion Pharmaceuticals raised $200M (Post-IPO Equity) on October 15, 2026.
  • Os Therapies raised $7.2M on October 15, 2026.
  • X4 Pharmaceuticals raised $150M (Debt Financing) on October 12, 2026.
  • CollPlant Biotechnologies Ltd raised $9.2M on October 9, 2026.

Who to call at Araceli Biosciences, and when

A new round usually means Araceli Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Araceli Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Araceli Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Araceli Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Araceli Biosciences

Location

Tigard, Oregon, United States

About

Araceli Biosciences is transforming therapeutic discovery with technologies built for speed, precision, and impact. Our advanced High Content Imaging platforms deliver real-time analysis, giving researchers immediate, actionable answers during experiments. Responding at the pace of biology accelerates decision-making, improves candidate selection, and reduces costly downstream failures.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Araceli Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJonathan D., Vice President WW Sales and SupportSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Araceli Biosciences's next move

See what Strategic adds

Araceli Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.